Category Archives: Stockholm

Still no treatment in Europe for the 14 million FMS patients trapped in pain!

From the FMS Global News Desk of Jeanne Hambleton (UK)

Press Release from ENFA – 29.04.2009

Brussels, (29.04.2009)

Last week was high on activities for the Fibromyalgia community, on one hand the European Network of Fibromyalgia Associations (ENFA) met with the European Health Commissioner Ms Androulla Vassiliou1. And on the other hand the European Medicines Agency (EMEA) gave another negative decision for a treatment for fibromyalgia in Europe2.

Ms. Pam Stewart, Vice-President of European Network of Fibromyalgia Associations (ENFA) and chairman of the trustees of Fibromyalgia Association UK, said one of the biggest challenges that the patients have been facing is the lack of officially recognised medical treatment options in the European Union.

By comparison there are three drugs in the United States of America approved by the Food and Drug Administration: Cymbalta from Eli Lilly, Lyrica from Pfizer and recently authorised Savella from Forest and Cypress (Pierre Fabre).

Last October, Cymbalta received a negative decision from the EMEA and last week was the turn of Lyrica said Ms Stewart. One dossier is still remaining to be evaluated by the EMEA: Savella. Each of these drugs has a limited success and judged alone leads to their failure to get approval.

However with a full range of treatment options, more people with fibromyalgia could have reduced levels of pain. This could enable them to embark on a management programme to significantly improve their quality of life said the Vice President.

“We are constantly hearing from people diagnosed with fibromyalgia that their doctor tells them there is no treatment because no approved guidelines or medications are available. Medical professionals that do not have time to research treatment options should have clearly signposted guidelines for effective treatment options. No one should be sentenced to a life of pain, she said.

“Patients across Europe are currently using these medicines off label. However, the European Medicines Agency told European Network of Fibromyalgia Associations that this is a common situation already faced in other disease areas such as cancer, and the situation with off label use cannot be taken into consideration in the assessment of medicines for which a marketing authorisation is sought.

“The difference with Fibromyalgia is that patients in the UK, for example, are unlikely to be prescribed any of these effective drugs because they have not been officially approved for Fibromyalgia. Patients are left with inadequate treatment options and although these drugs can be purchased over the Internet, this means their use is not monitored and people could be at the mercy of unscrupulous suppliers, which could put their lives at risk,” said Ms. Stewart.

Another example, coming from Germany, concerns the social status of patients since they are labeled as “depressive patient” for their life insurance or health insurance in order to have their drugs fully reimbursed by the National Health Insurance. In order to get any effective medicines, doctors should not diagnose fibromyalgia at all because the medicines are not indicated for fibromyalgia.

At the same time, an ENFA delegation was meeting with the European Health Commissioner Ms. Vassiliou. The meeting was only a natural step, concluding ENFA’s activities on the ‘European Institutions Fibromyalgia Awareness Campaign’ launched in 2008 on World Fibromyalgia Day.

Since the commencement of the campaign last May, with the support from 418 Members of the European Parliament, the Written Declaration on Fibromyalgia was adopted by the European Parliament in December 2008. The written declaration was necessary to raise awareness to all the European politicians from the 27 member states. It also helps create a mapping of the disease status disparity across Europe and increase awareness of better diagnosis and treatment.

“However, we realised that without any officially approved treatment options available, it was almost impossible to properly raise awareness of Fibromyalgia. The patient petition with over 27,000 signatures from all over Europe that MEP Adamou voluntarily hand delivered to the Health Commissioner, clearly demonstrates the frustration from the fibromyalgia community and strong and urgent needs to have treatment options to be officially available. The Fibromyalgia community is left with one hope to see maybe Savella drug approved before the summer. But unfortunately, the hope for a multiple choice of treatment in Europe seems to be lost.

“The European Network of Fibromyalgia Associations and all its associations have for years raised awareness on Fibromyalgia among national and European politicians, health professionals and the general public, and will keep on being active as long as it is necessary,” the Vice President.


About ENFA

ENFA is a network of patient association and support groups working in close consultation with the national association in the relevant country. Our joint missions are to conquer the myths and misunderstandings around Fibromyalgia. The network will help collectively push forward the boundaries which currently exist in understanding, experiencing and treatment of Fibromyalgia. Our main goal is to see Fibromyalgia receiving the recognition it deserves across Europe as an illness in its own right.

About Fibromyalgia

Fibromyalgia is a complex disease with chronic widespread pain as the defining symptom and various additional symptoms including fatigue, non-restorative sleep, morning stiffness, irritable bowel and bladder, restless legs, depression, anxiety and cognitive dysfunction often referred to as “fibro fog.” All of these symptoms cause serious limitations in patients’ ability to perform ordinary daily chores and work and severely affect their quality of life. Fibromyalgia imposes a large economic burden on society as well as on affected individuals. A study shows that an average patient in Europe consults up to 7 physicians and takes multiple medications over 5-7 years before receiving the correct diagnosis. The debilitating symptoms often result in lost work days, lost income and disability payments.

In fact, a Dutch study in 2005 estimated that the average annual cost of fibromyalgia was €980 million in the Netherlands. Research in the UK has shown that diagnosis and positive management of Fibromyalgia reduce healthcare cost by avoiding unnecessary investigations and consultations.

For more information on the European Network of Fibromyalgia Associations (ENFA) contact Ms. Pam Stewart Vice-President of ENFA Brussels@enfa-europe.eu; http://www.enfa-europe.eu.
1 On Wednesday 22 April in Strasbourg, for more information visit http://www.enfa-europe.eu; 2 On Thursday 23 April in London, for more information visit http://www.emea.europa.eu

WOMEN IN NETS CLAIMING TO BE TRAPPED IN PAIN IN 8 EUROPEAN CITIES

From the Fibromyalgia News Desk of Jeanne Hambleton

PRESS RELEASE Embargoed until 7.3.09

Brussels, (07.03.2009) – This Saturday has not only been marked by the International Women’s Day but also by the European action day on Fibromyalgia. While normal people were doing their usual Saturday’s shopping, the European Network of Fibromyalgia Associations and its Member Associations gathered together in eight European cities centres to expose their situation as women-patients suffering from fibromyalgia.

Simultaneously at 16:00 (Brussels time) in Paris, London, Amsterdam, Frankfurt, Brussels, Dublin, Milan, Lisbon and Madrid a passive demonstration took place where fibromyalgia community members trod the pavements of these cities.

The actual main issue around Fibromyalgia is that currently in Europe there is no recognized treatment whereas in the USA there are already 3 medicines available.

“This year has been declared the year against fibromyalgia by the European arm of the International Association for the Study of Pain (IASP-EFIC) and for this reason ENFA, as the European umbrella of fibromyalgia organisations wish to inform as much as possible not only diagnosed patients, but the general public, medical professionals, policy makers and politicians” says Pam Stewart, ENFA’s vice-president.

“Early diagnosis, diagnosis, treatments and information are still lacking for the estimated 14 million patients in Europe” says Robert Boelhouwer, ENFA’s president. “We have to keep on mobilizing the general public but also the politicians by having regular action days and awareness campaigns. This is the first event in 2009; the next one will take place in May on the occasion of the “International Fibromyalgia Awareness Day”, then in September and October. We will keep on fighting until we get a full and clear recognition of our disease, starting with a treatment approved for Europe,” he added.

Last December, 418 Members of the European Parliament from the 27 European countries expressed their wish to the European Commission and to the Member States to help raise awareness of the condition and facilitate access to information for health professionals and patients, by supporting European and national awareness campaigns; to encourage Member States to improve access to diagnosis and treatment; to facilitate research on fibromyalgia through the work programmes of the EU 7th Framework Programme for Research and future research programmes; and finally to facilitate the development of programmes for collecting data on fibromyalgia. The European Parliament has been the first European Institution to answer the call of the fibromyalgia community. The European Commission has been also recently been contacted but no reaction has came from them yet.

Fibromyalgia is a complex disease with a variety of symptoms in addition to the defining symptom – chronic widespread pain. These include fatigue, non-restorative sleep, morning stiffness, irritable bowel and bladder, restless legs, anxiety and cognitive dysfunction often referred to as “fibro fog.” All of these symptoms cause serious limitations in patients’ ability to perform ordinary daily chores and work and severely affect their quality of life. Some scientists believe that there is an abnormality in how the body responds to pain, and particularly a heightened sensitivity to stimuli.

Fibromyalgia imposes large economic burdens on society as well as on affected individuals. A study shows that an average patient in Europe consults up to 7 physicians and takes multiple medications over 5-7 years before receiving the correct diagnosis. The debilitating symptoms often result in lost work days, lost income and disability payments. Research in the UK has shown that diagnosis and positive management of Fibromyalgia reduce healthcare cost by avoiding unnecessary investigations and consultations.

Contact:Mr. Robert Boelhouwer President European Network of Fibromyalgia Associations (ENFA)
ENFA contact@enfa-europe.euhttp://www.enfa-europe.eu

EUROPEAN NETWORK of FIBROMYALGIA ASSOCIATIONS

From the News Desk of Jeanne Hambleton

PRESS RELEASE -28.01.2009

 

The European Medicines Agency (EMEA) are to  have a consultation with a delegation from the European Network of Fibromyalgia Associations (ENFA) in an attempt to understand the need for medical treatments for fibromyalgia in Europe.


Brussels –
Following an invitation by the EMEA, the European Network of Fibromyalgia Associations (ENFA) has agreed to attend a consultation meeting with EMEA, where ENFA representatives will share their knowledge and experiences related to the disease of Fibromyalgia that some 14 million Europeans are suffering from.  One of the biggest challenges that the patients have been facing is the lack of officially recognized medical treatment options in the European Union whereas there are three drugs in the United States of America approved by the Food and Drug Administration: Cymbalta from Eli Lilly, Lyrica from Pfizer and recently authorised Savella from Forest & Cypress.

 

The European Declaration 69/2008 on Fibromyalgia that has been recently adopted by the European Parliament, symbolizing the awareness raised around Fibromyalgia, calls for actions on specific issues from European Institutions to improve healthcare surrounding the disease, e.g. investment in research and provision of better diagnosis and treatment.  In addition, the European Health Commissioner Ms. Vassiliou’s remarks (E-6262/08EN) on the treatment of Fibromyalgia demonstrates encouraging willingness of the European Commission to address various concerns laid out in the Declaration on Fibromyalgia.

“We hope that this new drive on Fibromyalgia awareness will bring the end to the impasse of medical treatment for Fibromyalgia patients in the EU”, said Mr. Robert Boelhouwer, President of ENFA. 

Fibromyalgia is a complex disease with a variety of symptoms in addition to the defining symptom – chronic widespread pain. It is estimated that 14 million people in Europe suffer from fibromyalgia and the condition is more prevalent with women (87%).  Fibromyalgia imposes large economic burdens on society as well as on affected individuals. The debilitating symptoms often result in lost work days, lost income and disability payments. Due to lack of awareness, on average patients in Europe see 3-4 physicians and take multiple medications over the course of several years before they receive a diagnosis of Fibromyalgia.

Mr. Boelhouwer said, “Increasing awareness of Fibromyalgia among healthcare professionals and patients will bring enormous benefits to patients, healthcare providers and the society in general by managing the burden of the disease.” he continues, “Having this in mind, ENFA welcomes the proactive role that both the European Parliament and the European Commission have taken up in raising the awareness of Fibromyalgia.”

 

 

Contact:  European Network of Fibromyalgia Associations (ENFA)

Mr. Robert Boelhouwer President of ENFA

contact@enfa-europe.eu  - www.enfa-europe.eu


 About ENFA

ENFA is a network of patient association and support groups working in close consultation with the national association in the relevant country. Our joint missions are to conquer the myths and misunderstandings around Fibromyalgia. The network will help collectively push forward the boundaries which currently exist in understanding, experiencing and treatment of Fibromyalgia. Our main goal is to see fibromyalgia receiving the recognition it deserves across Europe as an illness in its own right.


 

 

Declaration of the European Parliament on fibromyalgia (1.26.2.)

From the News Desk of Jeanne Hambleton 

 
Bulletin EU 1/2-2009 - Health and consumer protection (2/3) PROVISIONAL VERSION

1.26.2. Declaration of the European Parliament on fibromyalgia.

Adopted by the European Parliament on 13 January. Parliament called on the Council and the Commission to:

  • develop a Community strategy on fibromyalgia in order to recognise this condition as a disease;
     
  • help raise awareness of the condition and facilitate access to information for health professionals and patients, by supporting EU and national awareness campaigns;
     
  • encourage Member States to improve access to diagnosis and treatment;
     
  • facilitate research on fibromyalgia through the work programmes of the seventh framework programme for research and technological development and future research programmes;
     
  • facilitate the development of programmes for collecting data on fibromyalgia.
  • European Network of Fibromyalgia Associations

    From the desk of Jeanne Hambleton

    Members of the European Parliament (MEPs) adopt written declaration 69/2008 on fibromyalgia initiated by five deputies and the European Network of Fibromyalgia Associations (ENFA).

    Brussels (16.12.2008) – Written Declaration 69/2008 on fibromyalgia has been a success in the European Parliament by finding the necessary quorum of signatories of 393 deputies giving their support. The Written Declaration was initiated by five key MEPs active on health at the European Parliament: Mr. Adamou, Ms. Brepoels, Ms. Dičkuté, Mr. Popa and Ms. Sinnott. These MEPs decided to launch the declaration during the celebratory meeting of the 1st European Fibromyalgia Awareness Day in May 2008, organized by ENFA

    The Written Declaration is calling on the European Union to recognize fibromyalgia in Europe as a disease, as WHO did in 1992. It is estimated that 14 million people in Europe suffer from fibromyalgia and the condition is more prevalent with women (87% of total prevalence).

    Fibromyalgia is a complex disease with a variety of symptoms in addition to the defining symptom – chronic widespread pain. These include fatigue, non-restorative sleep, morning stiffness, irritable bowel and bladder, restless legs, depression, anxiety and cognitive dysfunction often referred to as “fibro fog.” All of these symptoms cause serious limitations in patients’ ability to perform ordinary daily chores and work and severely affect their quality of life. Some scientists believe that there is an abnormality in how the body responds to pain, and particularly a heightened sensitivity to stimuli.

    Fibromyalgia imposes large economic burdens on society as well as on affected individuals. A study shows that an average patient in Europe consults up to 7 physicians and takes multiple medications over 5-7 years before receiving the correct diagnosis. The debilitating symptoms often result in lost work days, lost income and disability payments. Research in the UK has shown that diagnosis and positive management of Fibromyalgia reduce healthcare cost by avoiding unnecessary investigations and consultations

    Thus, the European Parliament is calling through this declaration, for the European Commission and the Council, to help raise awareness of the condition and facilitate access to information for health professionals and patients, by supporting European and national awareness campaigns; to encourage Member States to improve access to diagnosis and treatment; to facilitate research on fibromyalgia through the work programmes of the EU 7th Framework Programme for Research and future research programmes; and finally to facilitate the development of programmes for collecting data on fibromyalgia.

    Educating healthcare professionals, patients and the public to promote better understanding and management of Fibromyalgia will benefit patients, healthcare providers and the society.
    A Written Declaration is a text of up to 200 words on a matter falling within the European Union’s sphere of activities. MEPs can use them in order to launch or relaunch a debate on a subject that comes within the EU’s remit. At the end of the lapsing date (3 months after its launch on 1 September for the declaration 69/2008) the declaration is forwarded to the institutions named in the text, together with the names of the signatories.

    Contact:
    European Network of Fibromyalgia Associations (ENFA)
    Mr. Robert Boelhouwer
    President of ENFA
    contact@enfa-europe.eu
    www.enfa-europe.eu

    About ENFA
    ENFA is a network of patient association and support groups working in close consultation with the national association in the relevant country. Our joint missions are to conquer the myths and misunderstandings around Fibromyalgia. The network will help collectively push forward the boundaries which currently exist in understanding, experiencing and treatment of Fibromyalgia. Our main goal is to see fibromyalgia receiving the recognition it deserves across Europe as an illness in its own right.

    PIERRE FABRE MEDICAMENT AND FOREST LABORATORIES TO COLLABORATE ON DEVELOPMENT AND COMMERCIALIZATION

      PDF Print E-mail

    From the Desk of Jeanne Hambleton – courtesy PR-Canada.Net. 

     (http://pr-canada.net/index.php?option=com_content&task=view&id=71522&Itemid=61)

    Saturday, 27 December 2008
    Forest Laboratories, Inc. and Pierre Fabre Medicament today announced that they have entered into a definitive collaboration agreement to develop and commercialize F2695 in the United States and Canada. F2695 is a proprietary selective norepinephrine and serotonin reuptake inhibitor that is being developed by Pierre Fabre for the treatment of depression and other central nervous system disorders.
      

    Under the terms of the agreement, Forest will make an upfront payment to Pierre Fabre of $75 million and will pay future, undisclosed milestone payments. In addition, Pierre Fabre will receive royalty payments based on F2695 sales. Forest will assume responsibility for the clinical development and commercialization of F2695 in the United States and Canada, while Pierre Fabre will fund all preclinical development and drug substance manufacturing activities worldwide.

    “We are pleased to expand our relationship with Pierre Fabre to include this collaboration on the development of F2695 for the treatment of depression. Pierre Fabre has been an outstanding partner for Forest since we commenced our alliance in 2004,” commented Howard Solomon, Chairman and Chief Executive Officer of Forest. “We are highly encouraged by the strong clinical antidepressant activity and good tolerability exhibited by F2695 in the recently completed placebo-controlled, double-blind Phase II study. We look forward to initiating Phase III studies with F2695 next year. F2695 is the second late-stage product candidate we have licensed this quarter, underscoring our commitment to further building our pipeline and bringing novel therapeutics to the market.”

    “Pierre Fabre is looking forward to working with Forest on this exciting product opportunity,” said Jean-Pierre Garnier, Chief Executive Officer of Pierre Fabre Medicament. “Forest has an excellent record of developing and commercializing products for the treatment of depression and we are happy to extend our existing partnership to include F2695.”

    In a recently completed European placebo-controlled, double-blind Phase II study of F2695 in over 550 patients with major depressive disorder, the compound demonstrated statistically significant improvement compared to placebo (p<0.0001) on the primary endpoint, change from baseline in total score on the Montgomery-Asberg Depression Rating Scale (“MADRS”). Statistically significant improvement for F2695 compared to placebo was also demonstrated using the change from baseline in the Hamilton Depression Rating Scale (“HAMD-17″) and in response and remission rates using both the MADRS and HAMD-17. In addition, F2695 demonstrated improvement compared to placebo within two weeks after treatment initiation.

    About F2695

    F2695 is an isomer of milnacipran and is protected by a method of use patent that extends through June 2023. F2695 exerts its effects by selectively inhibiting the reuptake of both norepinephrine and serotonin, two neurotransmitters known to play an essential role in regulating mood. Forest, in partnership with Cypress Bioscience, Inc. and Pierre Fabre, is currently developing milnacipran; a selective serotonin and norepinephrine dual reuptake inhibitor, for the management of fibromyalgia. The New Drug Application is under FDA review and we continue to plan for a first quarter 2009 product launch meeting

    About Pierre Fabre Medicament

    The Pierre Fabre Group, the second largest independent laboratory in France, employs some 10,000 people, and achieved a turnover of 1.7 billion euros in 2007. The lines of business are ethical medicine, family health but also in dermo-cosmetic products with several brands: Avene, Ducray, A-Derma, Galenic, Klorane and Rene Furterer and dermo-cosmetics. Pierre Fabre Medicament, the pharmaceutical branch of the Pierre Fabre Group, made Research and Development its core business and the key to its future. With 1,400 employees dedicated to R&D, Pierre Fabre Medicament has invested 30% of its annual sales to R&D during 2008, in five major therapeutic areas in terms of public health: oncology (the priority R&D area of Pierre Fabre Medicament, with 50% of all R&D expenses), psychiatry, urology, cardio-vascular, rheumatology. To learn more about Pierre Fabre, visit http://www.pierre-fabre.com.

    About Forest Laboratories

    Forest Laboratories is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people’s lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest’s current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The company is headquartered in New York, NY. To learn more about Forest Laboratories, visit http://www.FRX.com.

    Except for the historical information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in Forest Laboratories’ Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and any subsequent SEC filings. 

     

    EUROPEAN FIBROMITES ARE DENIED CYMBALTA/DULOXETINE

    By Jeanne Hambleton © 2008

    News that the drug Cymbalta/Xeristar, a medicine containing the active substance duloxetine, will not be approved in Europe as the first official drug to treat fibromyalgia has been announced, causing grave concern to those who suffer with pain 24/7. This has led to fears that the decision may lead to more delays in a UK approval of new drugs to bring relief to fibromyalgia patients. There are currently no approved drugs for the treatment of Fibromyalgia available to UK patients.

    This follows news that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency have adopted a negative opinion, recommending the refusal of a change to the marketing authorisation for the medicinal product Cymbalta/Xeristar 30 mg and 60 mg gastroresistant capsules for treatment of Fibromyalgia.

    Cymbalta is the first medication for Fibromyalgia treatment that has been filed in Europe by Eli Lilly for the treatment of this invisible disability. The medicine was approved by the US Food and Drug Administration (FDA) for Fibromyalgia in June 2008.

    The European Network for Fibromyalgia Associations suspect that the misperception, even among some medical professionals in Europe, that fibromyalgia is not a real medical condition may have contributed to the decision. Despite the fact that the World Health Organisation (WHO) has recognized Fibromyalgia as a disease in 1992, and several well respected medical organizations including the European League Against Rheumatism (EULAR), the American College of Rheumatology and the American Pain Society (APS) have developed criteria and guidelines for the classification and treatment of fibromyalgia, some medical professionals and some governments in Europe have been slow to recognise Fibromyalgia as a disease.

    Cymbalta/Xeristar is a medicine containing the active substance duloxetine. It is available as gastroresistant capsules. Cymbalta/Xeristar was authorised for this purpose in December 2004. It is also used for adults with major depression; pain due to diabetic peripheral neuropathy (damage to the nerves in the extremities that can occur in patients with diabetes); and generalised anxiety disorder (long-term anxiety or nervousness about everyday matters).

    In the European Medicines Agency press release from Canary Wharf, London, it states the major concerns that led the committee to recommend the refusal of the change to the marketing authorisation, came from concern that the effectiveness of Cymbalta/Xeristar in treating fibromyalgia had not been shown sufficiently. The results of five studies involving a total of 1,718 adults with fibromyalgia were submitted to the CHMP. Four of these were short term and one long term involving 307 patients.

    In the short-term studies, the CHMP considered that the effect of Cymbalta/Xeristar was too small to be relevant for patients. There was no clear demonstration of improvement in symptoms and the modest effects of Cymbalta/Xeristar could be due to the medicine’s effect of improving the patients’ mood. The CHMP also concluded that the long-term study was insufficient to show the effectiveness of the medicine and that a long-term study comparing Cymbalta/Xeristar with placebo would be needed.

    The CHMP was of the opinion that the benefits of Cymbalta/Xeristar in the treatment of fibromyalgia did not outweigh its risks and recommended that the change to the marketing authorisation be refused.

    Mr. Robert Boelhouwer, President of the European Network for Fibromyalgia Associations (ENFA), expressed his concern following months of work in Brussels with the European Parliament to raise awareness, establishing a declaration for acceptance by the ENFA countries and promoting a petition for the recognition of Fibromyalgia.

    He said, “The ENFA encourages the regulatory agency and its professional committee members to recognise the sufferings that the patients have been enduring and approve other effective and safe treatment options as soon as possible. This negative recommendation has put the 14 million Fibromyalgia patients in Europe in despair. They have been hoping to have access to the first innovative medicine to treat their disease. I cannot believe that Fibromyalgia patients in Europe cannot have an access to the medicine that has been helping the patients in the US and other countries in the world.”

    The latest ENFA press release suggests that the misperception even among some medical professionals in Europe that fibromyalgia is not a ‘real’ medical condition may have contributed to the decision. Despite the fact that the World Health Organisation (WHO) has recognised Fibromyalgia as a disease in 1992, and several well respected medical organisations including the European League Against Rheumatism (EULAR), the American College of Rheumatology and the American Pain Society (APS) have developed criteria and guidelines for the classification and treatment of fibromyalgia, some medical professionals and some governments in Europe have been slow to recognise Fibromyalgia as a disease.

    The ENFA claim it is estimated that about 12-14 million people in Europe suffer from fibromyalgia and the epidemic is more prevalent with women (87% of total prevalence). Due to the complex pathology of the disease, a comprehensive diagnosis requires multi-disciplinary approach. A recent global survey showed that healthcare professionals lack confidence in diagnosing and managing Fibromyalgia. Educating healthcare professionals, patients and the public to promote better understanding and management of Fibromyalgia will benefit patients, healthcare providers and the society. Some scientists believe that there is an abnormality in how the body responds to pain, and particularly a heightened sensitivity to stimuli.

    Currently, two medicines have been approved in the US to treat Fibromyalgia. The US Food and Drug Administration, the equivalent of the EMEA in Europe, has approved the first medicine Lyrica (pregabalin) in June 2007 for specifically treating fibromyalgia and Cymbalta (duloxetine hydrochloride) in June 2008. Both Lyrica and Cymbalta are proven to reduce pain and to improve function in people with Fibromyalgia.
    Fibromyalgia imposes large economic burdens on the society as well as on affected individuals. A study shows that an average patient in Europe consults up to seven physicians and takes multiple medications over 5-7 years before receiving the correct diagnosis. The debilitating symptoms often result in lost work days, lost income and disability payments. In fact, a Dutch study in 2005 estimates that the average annual cost of fibromyalgia is €980 million in the Netherlands. Research in the UK has shown that diagnosis and positive management of Fibromyalgia reduce healthcare cost by avoiding unnecessary investigations and consultations

    The ENFA describes Fibromyalgia as a complex disease with chronic widespread pain as the defining symptom and various additional symptoms including fatigue, non-restorative sleep, morning stiffness, irritable bowel and bladder, restless legs, depression, anxiety and cognitive dysfunction often referred to as “fibro fog.” All of these symptoms cause serious limitations in patients’ ability to perform ordinary daily chores and work and severely affect their quality of life.

    As with all new medication the patient’s information leaflet and details of potential side effects should be read before taking any medication.

    [Perceived pain and weather changes in rheumatic patients]

    [Article in Portuguese]

    Miranda LC, Parente M, Silva C, Clemente-Coelho P, Santos H, Cortes S, Medeiros D, Ribeiro JS, Barcelos F, Sousa M, Miguel C, Figueiredo R, Mediavilla M, Simões E, Silva M, Patto JV, Madeira H, Ferreira J, Micaelo M, Leitão R, Las V, Faustino A, Teixeira A.
    Instituto Português de Reumatologia. luis.miranda@ipr.pt

    INTRODUCTION: Rheumatic patients with chronic pain describe in a vivid way the influence of climate on pain and disease activity. Several studies seem to confirm this association.

    OBJECTIVES: To evaluate and compare in a population of rheumatic patients the perceived influence of weather changes on pain and disease activity.

    METHODS: This is a retrospective cross-sectional study. For three weeks an assisted self-reported questionnaire with nine dimensions and a VAS pain scale was performed on consecutive out-patients in our clinic.

    RESULTS: 955 patients 787 female 168 male mean age 57.9 years with several rheumatologic diagnosis were evaluated. Overall 70 of the patients believed that the weather influenced their disease and 40 believed that the influence was high. Morning stiffness was influenced in 54 high influenced in 34 . Autumn and Winter were the most influential periods as well as humidity 67 and low temperatures 59 .

    CONCLUSION: In our study as well as in literature we found that a high percentage of patients 70 perceived that weather conditions influenced their pain and disease. Fibromyalgia patients seemed to be strongly influenced by weather changes. Our study confirms that patients perception on the influence of climate on pain and therefore their disease is an important clinical factor and it should be considered when evaluating rheumatic patients.

    PMID: 18159202 [PubMed - in process]

    Source

    FMS Global News

    Fibrohugs Support

    Tenderpoints Newsletter

    CONGO’S BILL AND THE RACE AGAINST TIME

    by Jeanne Hambleton  © 2008
    NFA Leader Against Pain-Advocate  

    A committee of the New Jersey Senate has considered a new bill called Congo’s Law and there are hopes that Congo, the German Shepherd dog, will no longer be under sentence of death.

    See original story: Congo gets world wide support

    Congo was put on “death row” last June as a vicious dog after protecting his mistress, a female dog and three puppies, from an alleged attack with rake by a gardening contractor. When news of her fate reached the Internet animal activists and dog lovers all over the world signed petitions and sent emails to the Judge in Princeton, home of Congo, to save the dog’s life.

    This week thanks to a friend, Anne Soden, who lives in Princeton and took part in one of the demonstrations to save Congo, I can bring you news that an American Assemblyman called Neil M Cohen from the New Jersey Senate has proposed a Bill to save the life of Congo, the German Shepherd dog sentenced to death. Thanks Anne.

    Neil Cohen is quoted as saying,”Congo’s case underscores the need for the state to modernize the law that deals with dog attacks so it is fair for the owners and the animals.”

    Congo’s Bill would revise state animal control law provisions that are alleged to be archaic and barbaric, by making it more difficult to label a dog vicious or to put an animal down.

    But a USA website (http://abbyK9.blogspot.com) which shows a picture of two of the James children with Congo, adds a cautious note to say, “Please note that Congo being returned to his family is only temporary while the case goes through the appeal. Congo could still be put to sleep for protecting her family. So please, keep contacting the governor’s office to have this matter put to rest once and for all. The calls and emails are helping!” Details of who and where to write or email appear later in this story.

    NEW JERSEY SENATE

    In December Congo’s Bill, that would immediately change the state’s vicious dog laws, made its first passage through the Senate.

    The New Jersey Assemblyman Neil Cohen, who took this action, is an avid defender of the rights of animals and has sponsored several measures to ensure the humane treatment of animals. He has met Congo and his owners, the James family, at their home in Princeton to raise awareness of his legislation and the dog’s potential fate. Neil Cohen says that under current law the only defense for a dog declared vicious is if the dog has been provoked and acted in defense to protect itself, its offspring, its owner or a family member of the owner.

    “The nature of a dog is to protect those around them,” said the Assemblyman. “It’s outrageous that Congo may have been provoked into attacking and this fact is being ignored by authorities.”

    A lawyer for Congo’s owners has argued that Congo was provoked when the dog mauled a landscaper on June 5 outside a home in Princeton Township. Neil Cohen’s bill (A-4597) will clarify and revise the current vicious dog law to make it more equitable.

    The bill would take into consideration provocation by treating a dog provoked to attack differently than an unprovoked dog that caused bodily injury to a person or domestic animal during an attack.

    The Assemblyman said the bill would define striking, grabbing, poking and prodding as threatening actions and behaviors that could incite a dog to defend itself, its offspring or its owner or the owner’s family. The legislation would raise the bar for declaring a dog as vicious. It would require a dog to be found vicious beyond a reasonable doubt — the same standard used for humans charged with a crime. The measure also would give municipal courts an alternative to humanely destroying a vicious dog by giving the owner the option to comply with precautions for keeping a potentially dangerous dog.

    During the disposition and appeals process, the bill would allow an owner to keep their dog as long as they complied with current law’s precautions for keeping a potentially dangerous dog. Precautions for owners keeping a dog deemed potentially dangerous include posting signs on their property and minimizing a dog’s potential threat to people and other animals. The bill also would allow an owner and owner’s family to visit their dog during times when their dog might be impounded. The bill would establish a three-month statute of limitations for animal control officer to seize and impound alleged vicious or potentially dangerous dogs.

    Neil Cohen said the vicious dog law has not been amended since 1994 and it is long overdue for an update. He hoped his legislation would be fast tracked into law to save the life of Congo.

    Congo was ruled vicious by Princeton Township Municipal Judge Russell Annich, Jr., who also ordered that the dog be put down. The judge’s decision has since been stayed and a state Superior Court Judge has allowed the dog to return to his home, pending appeal, with numerous restrictions, including that he is muzzled and kept in a fenced area.

    The fate of Congo created a public debate that has lead to more telephone calls, emails, letters and faxes to Governor Jon S. Corzine’s office than any other issue since the governor took office.

    The Bill was carried by a vote of 5 to 0. It now heads to the Assembly Speaker who may or may not decide to post it for a vote by the full Assembly.

    ON LINE SUPPORT

    Broadcaster Warren Eckstein from Santa Monica, California, an internationally known pet and animal expert, has been carrying news of Congo’s Bill on his website.

    On December 19 Warren wrote that the New Jersey Assembly Agriculture and Natural Resources Committee today released legislation Assembly Deputy Speaker Neil M. Cohen crafted that would immediately change the state’s vicious dog laws.

    It was also reported – you will be pleased to hear – from Warren’s website that Congo and his partner Lucia are so happy to be back together.

    Elizabeth James on Warren’s website wrote, “I think the appeal could take months but we are optimistic. God willing, New Jersey Assemblyman Neil Cohen’s proposal of Congo’s Law will go through and that will be the first line of defense. We are still receiving mail and email from well wishers and supporters all around the globe! Thank you for all the support and we will keep you posted as we progress.”

    On another local website for Asbury Park Press, APP.com for Jersey for comments, blogs and shares, Tom Baldwin of Gannett State Bureau reported Assemblyman Neil Cohen, a professed dog-lover, is quoted as saying under this bill Congo gets saved and the bill gives municipal judges needed latitude to deal with dog-bite cases.

    Tom Baldwin continues and I smiled, “The story connects hot-issue circuitry. Mix the gentility of leafy, enlightened Princeton with the dog-lovers and the immigration debate — the landscaper is reported to have been an illegal from Honduras — and the story quickly won global appeal.
    “Locally, not since a whale swam up the Delaware River to freshwater Trenton in April 2005 has an animal story grabbed headlines, aside from some reported coyote attacks and New Jersey’s enduring debate over whether to allow hunters shoot black bears.”
    And finally Abby K 9 tells us the way to get Congo’s ruling reversed, hopefully, is to contact New Jersey governor Jim Corzine. His office is taking calls (and counting them) to support overturning the death sentence for Congo the German Shepherd.

    The governor’s office can be contacted at Office of the Governor, PO Box 001,Trenton, NJ 08625. Calling is preferred, (609-292-6000) but you can also email them through the website.

    http://www.nj.gov/cgi-bin/governor/govmail/govmail_1.pl

    Choose “Law & Public Safety” on the drop-down menu and on the next page, choose “Pardons & Clemency”. It only takes a few seconds to call – they are interested in the number of callers, not what you have to say – and it does not take much longer to email. Assemblyman Cohen telephone number is (908) 624-0880.

    CONGO’S BILL
    The following includes a statement from the Bill outlining the relevant details of Congo’s Bill.

    On December 17 Senate Bill No. 3019 (A.4597) was introduced for the 212th Legislature. The synopsis said it revises vicious and potentially dangerous dog law; designated Congo’s Law.

    The final Statement in the Act concerning vicious and potentially dangerous dogs and designated as Congo’s Law, and amending and supplementing P.L.1989, c.307.
    enacted by the Senate and General Assembly of the State of New Jersey said,

    “This bill clarifies and revises several provisions of the State law that address vicious and potentially dangerous dogs.  It is designated as Congo’s Law in recognition of Congo, a dog in Princeton, New Jersey, that was declared a vicious dog and subject to an order to be euthanized when, by many accounts, it was protecting its owner and the owner’s family members when a landscaping crew, against the owner’s instructions, came onto the owner’s property.

    “Specifically, the bill defines the terms ‘provoked’ and ‘unprovoked.’  Whether a dog is provoked or not is currently the only defense under the law to prevent a dog from being declared vicious when it is acting in defense of itself, its offspring, its owner, or a family member of its owner.  Also, under current law, if a municipal court declares a dog to be vicious, it must be humanely destroyed.  This bill provides the municipal court an alternative to humanely destroying a dog that is declared vicious.

    “Under the bill, the court may, for equitable reasons, choose an alternative to destroying the dog if the alternative is sufficient to protect the public and is at least as protective and restrictive as the precautions required for keeping a potentially dangerous dog.  The bill allows for an owner to keep the dog pending disposition of the case and any appeals if the owner agrees to comply with those precautions.  The precautions include posting certain signs on the property and minimizing the dog’s contact and threat to people and other animals in specific ways. 

    “In addition, the bill authorizes the court to modify certain requirements for potentially dangerous dogs, and vicious dogs that remain with their owners, to be reasonable, affordable and appropriate to the owner’s circumstances. The bill further provides for visitation by the owner and the owner’s family during any impoundment that is required.

    “Furthermore, the bill raises the burden of proof in most cases for finding a dog to be vicious or potentially dangerous to beyond a reasonable doubt, instead of by clear and convincing evidence.  The municipal burden of proof for demonstrating that a dog was not provoked or that the injury was not accidental would be by clear and convincing evidence.  The bill clarifies under the law’s hearing provisions to provide that a hearing on whether the dog is vicious or potentially dangerous will be held unless the owner agrees to relinquish ownership of the dog. 

    “The bill further requires the notice to the owner to inform the owner of the potential consequences of not replying to the notice within seven days.  Under current law and the bill, if the owner does not reply within seven days of the notice, or if the owner relinquishes ownership of the dog, the dog may be humanely destroyed.  The bill eliminates the requirement to tattoo a potentially dangerous dog.

    “The bill also modifies the provision under current law concerning liability insurance for potentially dangerous dogs.  The bill allows the court to order this insurance for potentially dangerous dogs, and if applicable, vicious dogs, if it is available.  Furthermore, the court is directed to determine a sufficient and reasonable amount of coverage and a reasonable cost for that coverage; and the insurance company is directed to notify the municipality of the coverage and any lapsing of the policy, if the company can lawfully do so.

    “Finally, the bill provides additional protections for the public by authorizing municipalities, if a municipality chooses to do so, to establish procedures for recording and investigating complaints about, and requiring appropriate notice to the public concerning, dogs within the jurisdiction of the municipality that are reported to exhibit menacing, threatening, or other aggressive behavior that may lead to injury to a person or a domestic animal, or that have injured a person but have not been the subject of an action pursuant to the State vicious and potentially dangerous dog law.  The municipality must establish these procedures and requirements by ordinance and it is authorized to require an owner of a dog subject to complaints to post signs or take other action determined necessary by the municipality for the protection of the public.

    “With Assembly Floor Amendments
    (Proposed By Assemblyman Cohen) ADOPTED: DECEMBER 13, 2007
     
    These amendments:
          (1) make changes to the definition of “provoked” in the bill;
          (2) remove certain time limitations by which certain actions may be taken in section 2 of the bill; and
          (3) change the municipal burden of proof with respect to whether the dog was not provoked or that the injury was not accidental from beyond a reasonable doubt to by clear and convincing evidence.

    Clause 15 states – This act shall take effect immediately, and shall apply to all pending cases and cases in the process of being adjudicated as of the date of enactment of this act, and to any dogs under court order for humane destruction as of January 1, 2007 but which have not been destroyed as of the date of enactment of this act.

    The Bill must now go before the Full Assembly.

    See Also: http://fmsglobalnews.wordpress.com/2007/12/02/congo-on-doggie-death-row-gets-worldwide-support-and-tv-publicity-for-his-reprieve/

    A committee of the New Jersey Senate has considered a new bill called Congo’s Law and there are hopes that Congo, the German Shepherd dog, will no longer be under sentence of death.

    Congo was put on “death row” last June as a vicious dog after protecting his mistress, a female dog and three puppies, from an alleged attack with rake by a gardening contractor. When news of his fate reached the Internet animal activists and dog lovers all over the world signed petitions and sent emails to the Judge in Princeton, home of Congo, to save the dog’s life.

    This week thanks to a friend, Anne Soden, who lives in Princeton and took part in one of the demonstration to save Congo, I can bring you news that an American Assemblyman called Neil M Cohen from the New Jersey Senate has proposed a Bill to save the life of Congo, the German Shepherd dog sentenced to death. Thanks Anne.

    Neil Cohen is quoted as saying,”Congo’s case underscores the need for the state to modernize the law that deals with dog attacks so it is fair for the owners and the animals.”

    Congo’s Bill would revise state animal control law provisions that are alleged to be archaic and barbaric, by making it more difficult to label a dog vicious or to put an animal down.

    But a USA website (http://abbyK9.blogspot.com) which shows a picture of two of the James children with Congo, adds a cautious note to say, “Please note that Congo being returned to his family is only temporary while the case goes through the appeal. Congo could still be put to sleep for protecting his family. So please, keep contacting the governor’s office to have this matter put to rest once and for all. The calls and emails are helping!” Details of who and where to write or email appear later in this story.

    NEW JERSEY SENATE

    In December Congo’s Bill, that would immediately change the state’s vicious dog laws, made its first passage through the Senate.

    The New Jersey Assemblyman Neil Cohen, who took this action, is an avid defender of the rights of animal and has sponsored several measures to ensure the humane treatment of animals. He has met Congo and his owners, the James family, at their home in Princeton to raise awareness of his legislation and the dog’s potential fate. Neil Cohen says that under current law the only defense for a dog declared vicious is if the dog has been provoked and acted in defense to protect itself, its offspring, its owner or a family member of the owner.

    “The nature of a dog is to protect those around them,” said the Assemblyman. “It’s outrageous that Congo may have been provoked into attacking and this fact is being ignored by authorities.”

    A lawyer for Congo’s owners has argued that Congo was provoked when the dog mauled a landscaper on June 5 outside a home in Princeton Township. Neil Cohen’s bill (A-4597) will clarify and revise the current vicious dog law to make it more equitable.

    The bill would take into consideration provocation by treating a dog provoked to attack differently than an unprovoked dog that caused bodily injury to a person or domestic animal during an attack.

    The Assemblyman said the bill would define striking, grabbing, poking and prodding as threatening actions and behaviors that could incite a dog to defend itself, its offspring or its owner or the owner’s family. The legislation would raise the bar for declaring a dog as vicious. It would require a dog to be found vicious beyond a reasonable doubt — the same standard used for humans charged with a crime. The measure also would give municipal courts an alternative to humanely destroying a vicious dog by giving the owner the option to comply with precautions for keeping a potentially dangerous dog.

    During the disposition and appeals process, the bill would allow an owner to keep their dog as long as they complied with current law’s precautions for keeping a potentially dangerous dog. Precautions for owners keeping a dog deemed potentially dangerous include posting signs on their property and minimizing a dog’s potential threat to people and other animals. The bill also would allow an owner and owner’s family to visit their dog during times when their dog might be impounded. The bill would establish a three-month statute of limitations for animal control officer to seize and impound alleged vicious or potentially dangerous dogs.

    Neil Cohen said the vicious dog law has not been amended since 1994 and it is long overdue for an update. He hoped his legislation would be fast tracked into law to save the life of the Congo.

    Congo was ruled vicious by Princeton Township Municipal Judge Russell Annich, Jr., who also ordered that the dog be put down. The judge’s decision has since been stayed and a state Superior Court Judge has allowed the dog to return to his home, pending appeal, with numerous restrictions, including that he is muzzled and kept in a fenced area.

    The fate of Congo created a public debate that has lead to more telephone calls, emails, letters and faxes to Governor Jon S. Corzine’s office than any other issue since the governor took office.

    The Bill was carried by a vote of 5 to 0. It now heads to the Assembly Speaker who may or may not decide to post it for a vote by the full Assembly.

    ON LINE SUPPORT

    Broadcaster Warren Eckstein from Santa Monica, California, an internationally known pet and animal expert, has been carrying news of Congo’s Bill on his website.

    On December 19 Warren wrote that the New Jersey Assembly Agriculture and Natural Resources Committee today released legislation Assembly Deputy Speaker Neil M. Cohen crafted that would immediately change the state’s vicious dog laws.

    It was also reported – you will be pleased to hear – from Warren’s website that Congo and his partner Lucia are so happy to be back together.

    Elizabeth James on Warren’s website wrote, “I think the appeal could take months but we are optimistic. God willing, New Jersey Assemblyman Neil Cohen’s proposal of Congo’s Law will go through and that will be the first line of defense. We are still receiving mail and email from well wishers and supporters all around the globe! Thank you for all the support and we will keep you posted as we progress.”

    On another local website for Asbury Park Press, APP.com for Jersey for comments, blogs and shares, Tom Baldwin of Gannett State Bureau reported Assemblyman Neil Cohen, a professed dog-lover, is quoted as saying under this bill Congo gets saved and the bill gives municipal judges needed latitude to deal with dog-bite cases.

    Tom Baldwin continues and I smiled, “The story connects hot-issue circuitry. Mix the gentility of leafy, enlightened Princeton with the dog-lovers and the immigration debate — the landscaper is reported to have been an illegal from Honduras — and the story quickly won global appeal.
    “Locally, not since a whale swam up the Delaware River to freshwater Trenton in April 2005 has an animal story grabbed headlines, aside from some reported coyote attacks and New Jersey’s enduring debate over whether to allow hunters shoot black bears.”
    And finally Abby K 9 tells us the way to get Congo’s ruling reversed, hopefully, is to contact New Jersey governor Jim Corzine. His office is taking calls (and counting them) to support overturning the death sentence for Congo the German Shepherd.

    The governor’s office can be contacted at Office of the Governor, PO Box 001,Trenton, NJ 08625. Calling is preferred, (609-292-6000) but you can also email them through the website.

    http://www.nj.gov/cgi-bin/governor/govmail/govmail_1.pl

    Choose “Law & Public Safety” on the drop-down menu and on the next page, choose “Pardons & Clemency”. It only takes a few seconds to call – they are interested in the number of callers, not what you have to say – and it does not take much longer to email. Assemblyman Cohen telephone number is (908) 624-0880.

    CONGO’S BILL
    The following includes a statement from the Bill outlining the relevant details of Congo’s Bill.

    On December 17 Senate Bill No. 3019 (A.4597) was introduced for the 212th Legislature. The synopsis said it revises vicious and potentially dangerous dog law; designated Congo’s Law.

    The final Statement in the Act concerning vicious and potentially dangerous dogs and designated as Congo’s Law, and amending and supplementing P.L.1989, c.307.
    enacted by the Senate and General Assembly of the State of New Jersey said,

    “This bill clarifies and revises several provisions of the State law that address vicious and potentially dangerous dogs.  It is designated as Congo’s Law in recognition of Congo, a dog in Princeton, New Jersey, that was declared a vicious dog and subject to an order to be euthanized when, by many accounts, it was protecting its owner and the owner’s family members when a landscaping crew, against the owner’s instructions, came onto the owner’s property.

    “Specifically, the bill defines the terms ‘provoked’ and ‘unprovoked.’  Whether a dog is provoked or not is currently the only defense under the law to prevent a dog from being declared vicious when it is acting in defense of itself, its offspring, its owner, or a family member of its owner.  Also, under current law, if a municipal court declares a dog to be vicious, it must be humanely destroyed.  This bill provides the municipal court an alternative to humanely destroying a dog that is declared vicious.

    “Under the bill, the court may, for equitable reasons, choose an alternative to destroying the dog if the alternative is sufficient to protect the public and is at least as protective and restrictive as the precautions required for keeping a potentially dangerous dog.  The bill allows for an owner to keep the dog pending disposition of the case and any appeals if the owner agrees to comply with those precautions.  The precautions include posting certain signs on the property and minimizing the dog’s contact and threat to people and other animals in specific ways. 

    “In addition, the bill authorizes the court to modify certain requirements for potentially dangerous dogs, and vicious dogs that remain with their owners, to be reasonable, affordable and appropriate to the owner’s circumstances. The bill further provides for visitation by the owner and the owner’s family during any impoundment that is required.

    “Furthermore, the bill raises the burden of proof in most cases for finding a dog to be vicious or potentially dangerous to beyond a reasonable doubt, instead of by clear and convincing evidence.  The municipal burden of proof for demonstrating that a dog was not provoked or that the injury was not accidental would be by clear and convincing evidence.  The bill clarifies under the law’s hearing provisions to provide that a hearing on whether the dog is vicious or potentially dangerous will be held unless the owner agrees to relinquish ownership of the dog. 

    “The bill further requires the notice to the owner to inform the owner of the potential consequences of not replying to the notice within seven days.  Under current law and the bill, if the owner does not reply within seven days of the notice, or if the owner relinquishes ownership of the dog, the dog may be humanely destroyed.  The bill eliminates the requirement to tattoo a potentially dangerous dog.

    “The bill also modifies the provision under current law concerning liability insurance for potentially dangerous dogs.  The bill allows the court to order this insurance for potentially dangerous dogs, and if applicable, vicious dogs, if it is available.  Furthermore, the court is directed to determine a sufficient and reasonable amount of coverage and a reasonable cost for that coverage; and the insurance company is directed to notify the municipality of the coverage and any lapsing of the policy, if the company can lawfully do so.

    “Finally, the bill provides additional protections for the public by authorizing municipalities, if a municipality chooses to do so, to establish procedures for recording and investigating complaints about, and requiring appropriate notice to the public concerning, dogs within the jurisdiction of the municipality that are reported to exhibit menacing, threatening, or other aggressive behavior that may lead to injury to a person or a domestic animal, or that have injured a person but have not been the subject of an action pursuant to the State vicious and potentially dangerous dog law.  The municipality must establish these procedures and requirements by ordinance and it is authorized to require an owner of a dog subject to complaints to post signs or take other action determined necessary by the municipality for the protection of the public.

    “With Assembly Floor Amendments
    (Proposed By Assemblyman Cohen) ADOPTED: DECEMBER 13, 2007
     
    These amendments:
          (1) make changes to the definition of “provoked” in the bill;
          (2) remove certain time limitations by which certain actions may be taken in section 2 of the bill; and
          (3) change the municipal burden of proof with respect to whether the dog was not provoked or that the injury was not accidental from beyond a reasonable doubt to by clear and convincing evidence.

    Clause 15 states – This act shall take effect immediately, and shall apply to all pending cases and cases in the process of being adjudicated as of the date of enactment of this act, and to any dogs under court order for humane destruction as of January 1, 2007 but which have not been destroyed as of the date of enactment of this act.

    The Bill must now go before the Full Assembly.

    by Jeanne Hambleton  © 2008
    NFA Leader Against Pain-Advocate  

    A committee of the New Jersey Senate has considered a new bill called Congo’s Law and there are hopes that Congo, the German Shepherd dog, will no longer be under sentence of death.

    Congo was put on “death row” last June as a vicious dog after protecting his mistress, a female dog and three puppies, from an alleged attack with rake by a gardening contractor. When news of his fate reached the Internet animal activists and dog lovers all over the world signed petitions and sent emails to the Judge in Princeton, home of Congo, to save the dog’s life.

    This week thanks to a friend, Anne Soden, who lives in Princeton and took part in one of the demonstration to save Congo, I can bring you news that an American Assemblyman called Neil M Cohen from the New Jersey Senate has proposed a Bill to save the life of Congo, the German Shepherd dog sentenced to death. Thanks Anne.

    Neil Cohen is quoted as saying,”Congo’s case underscores the need for the state to modernize the law that deals with dog attacks so it is fair for the owners and the animals.”

    Congo’s Bill would revise state animal control law provisions that are alleged to be archaic and barbaric, by making it more difficult to label a dog vicious or to put an animal down.

    But a USA website (http://abbyK9.blogspot.com) which shows a picture of two of the James children with Congo, adds a cautious note to say, “Please note that Congo being returned to his family is only temporary while the case goes through the appeal. Congo could still be put to sleep for protecting his family. So please, keep contacting the governor’s office to have this matter put to rest once and for all. The calls and emails are helping!” Details of who and where to write or email appear later in this story.

    NEW JERSEY SENATE

    In December Congo’s Bill, that would immediately change the state’s vicious dog laws, made its first passage through the Senate.

    The New Jersey Assemblyman Neil Cohen, who took this action, is an avid defender of the rights of animal and has sponsored several measures to ensure the humane treatment of animals. He has met Congo and his owners, the James family, at their home in Princeton to raise awareness of his legislation and the dog’s potential fate. Neil Cohen says that under current law the only defense for a dog declared vicious is if the dog has been provoked and acted in defense to protect itself, its offspring, its owner or a family member of the owner.

    “The nature of a dog is to protect those around them,” said the Assemblyman. “It’s outrageous that Congo may have been provoked into attacking and this fact is being ignored by authorities.”

    A lawyer for Congo’s owners has argued that Congo was provoked when the dog mauled a landscaper on June 5 outside a home in Princeton Township. Neil Cohen’s bill (A-4597) will clarify and revise the current vicious dog law to make it more equitable.

    The bill would take into consideration provocation by treating a dog provoked to attack differently than an unprovoked dog that caused bodily injury to a person or domestic animal during an attack.

    The Assemblyman said the bill would define striking, grabbing, poking and prodding as threatening actions and behaviors that could incite a dog to defend itself, its offspring or its owner or the owner’s family. The legislation would raise the bar for declaring a dog as vicious. It would require a dog to be found vicious beyond a reasonable doubt — the same standard used for humans charged with a crime. The measure also would give municipal courts an alternative to humanely destroying a vicious dog by giving the owner the option to comply with precautions for keeping a potentially dangerous dog.

    During the disposition and appeals process, the bill would allow an owner to keep their dog as long as they complied with current law’s precautions for keeping a potentially dangerous dog. Precautions for owners keeping a dog deemed potentially dangerous include posting signs on their property and minimizing a dog’s potential threat to people and other animals. The bill also would allow an owner and owner’s family to visit their dog during times when their dog might be impounded. The bill would establish a three-month statute of limitations for animal control officer to
    seize and impound alleged vicious or potentially dangerous dogs.

    Neil Cohen said the vicious dog law has not been amended since 1994 and it is long overdue for an update. He hoped his legislation would be fast tracked into law to save the life of the Congo.

    Congo was ruled vicious by Princeton Township Municipal Judge Russell Annich, Jr., who also ordered that the dog be put down. The judge’s decision has since been stayed and a state Superior Court Judge has allowed the dog to return to his home, pending appeal, with numerous restrictions, including that he is muzzled and kept in a fenced area.

    The fate of Congo created a public debate that has lead to more telephone calls, emails, letters and faxes to Governor Jon S. Corzine’s office than any other issue since the governor took office.

    The Bill was carried by a vote of 5 to 0. It now heads to the Assembly Speaker who may or may not decide to post it for a vote by the full Assembly.

    ON LINE SUPPORT

    Broadcaster Warren Eckstein from Santa Monica, California, an internationally known pet and animal expert, has been carrying news of Congo’s Bill on his website.

    (http://wareneckstein.com)

    On December 19 Warren wrote that the New Jersey Assembly Agriculture and Natural Resources Committee today released legislation Assembly Deputy Speaker Neil M. Cohen crafted that would immediately change the state’s vicious dog laws.

    It was also reported – you will be pleased to hear – from Warren’s website that Congo and his partner Lucia are so happy to be back together.

    Elizabeth James on Warren’s website wrote, “I think the appeal could take months but we are optimistic. God willing, New Jersey Assemblyman Neil Cohen’s proposal of Congo’s Law will go through and that will be the first line of defense. We are still receiving mail and email from well wishers and supporters all around the globe! Thank you for all the support and we will keep you posted as we progress.”

    On another local website for Asbury Park Press, APP.com for Jersey for comments, blogs and shares, Tom Baldwin of Gannett State Bureau reported Assemblyman Neil Cohen, a professed dog-lover, is quoted as saying under this bill Congo gets saved and the bill gives municipal judges needed latitude to deal with dog-bite cases.

    Tom Baldwin continues and I smiled, “The story connects hot-issue circuitry. Mix the gentility of leafy, enlightened Princeton with the dog-lovers and the immigration debate — the landscaper is reported to have been an illegal from Honduras — and the story quickly won global appeal.
    “Locally, not since a whale swam up the Delaware River to freshwater Trenton in April 2005 has an animal story grabbed headlines, aside from some reported coyote attacks and New Jersey’s enduring debate over whether to allow hunters shoot black bears.”
    And finally Abby K 9 tells us the way to get Congo’s ruling reversed, hopefully, is to contact New Jersey governor Jim Corzine. His office is taking calls (and counting them) to support overturning the death sentence for Congo the German Shepherd.

    The governor’s office can be contacted at Office of the Governor, PO Box 001,Trenton, NJ 08625. Calling is preferred, (609-292-6000) but you can also email them through the website.

    http://www.nj.gov/cgi-bin/governor/govmail/govmail_1.pl

    Choose “Law & Public Safety” on the drop-down menu and on the next page, choose “Pardons & Clemency”. It only takes a few seconds to call – they are interested in the number of callers, not what you have to say – and it does not take much longer to email. Assemblyman Cohen telephone number is (908) 624-0880.

    CONGO’S BILL
    The following includes a statement from the Bill outlining the relevant details of Congo’s Bill.

    On December 17 Senate Bill No. 3019 (A.4597) was introduced for the 212th Legislature. The synopsis said it revises vicious and potentially dangerous dog law; designated Congo’s Law.

    The final Statement in the Act concerning vicious and potentially dangerous dogs and designated as Congo’s Law, and amending and supplementing P.L.1989, c.307.
    enacted by the Senate and General Assembly of the State of New Jersey said,

    “This bill clarifies and revises several provisions of the State law that address vicious and potentially dangerous dogs.  It is designated as Congo’s Law in recognition of Congo, a dog in Princeton, New Jersey, that was declared a vicious dog and subject to an order to be euthanized when, by many accounts, it was protecting its owner and the owner’s family members when a landscaping crew, against the owner’s instructions, came onto the owner’s property.

    “Specifically, the bill defines the terms ‘provoked’ and ‘unprovoked.’  Whether a dog is provoked or not is currently the only defense under the law to prevent a dog from being declared vicious when it is acting in defense of itself, its offspring, its owner, or a family member of its owner.  Also, under current law, if a municipal court declares a dog to be vicious, it must be humanely destroyed.  This bill provides the municipal court an alternative to humanely destroying a dog that is declared vicious.

    “Under the bill, the court may, for equitable reasons, choose an alternative to destroying the dog if the alternative is sufficient to protect the public and is at least as protective and restrictive as the precautions required for keeping a potentially dangerous dog.  The bill allows for an owner to keep the dog pending disposition of the case and any appeals if the owner agrees to comply with those precautions.  The precautions include posting certain signs on the property and minimizing the dog’s contact and threat to people and other animals in specific ways. 

    “In addition, the bill authorizes the court to modify certain requirements for potentially dangerous dogs, and vicious dogs that remain with their owners, to be reasonable, affordable and appropriate to the owner’s circumstances. The bill further provides for visitation by the owner and the owner’s family during any impoundment that is required.

    “Furthermore, the bill raises the burden of proof in most cases for finding a dog to be vicious or potentially dangerous to beyond a reasonable doubt, instead of by clear and convincing evidence.  The municipal burden of proof for demonstrating that a dog was not provoked or that the injury was not accidental would be by clear and convincing evidence.  The bill clarifies under the law’s hearing provisions to provide that a hearing on whether the dog is vicious or potentially dangerous will be held unless the owner agrees to relinquish ownership of the dog. 

    “The bill further requires the notice to the owner to inform the owner of the potential consequences of not replying to the notice within seven days.  Under current law and the bill, if the owner does not reply within seven days of the notice, or if the owner relinquishes ownership of the dog, the dog may be humanely destroyed.  The bill eliminates the requirement to tattoo a potentially dangerous dog.

    “The bill also modifies the provision under current law concerning liability insurance for potentially dangerous dogs.  The bill allows the court to order this insurance for potentially dangerous dogs, and if applicable, vicious dogs, if it is available.  Furthermore, the court is directed to determine a sufficient and reasonable amount of coverage and a reasonable cost for that coverage; and the insurance company is directed to notify the municipality of the coverage and any lapsing of the policy, if the company can lawfully do so.

    “Finally, the bill provides additional protections for the public by authorizing municipalities, if a municipality chooses to do so, to establish procedures for recording and investigating complaints about, and requiring appropriate notice to the public concerning, dogs within the jurisdiction of the municipality that are reported to exhibit menacing, threatening, or other aggressive behavior that may lead to injury to a person or a domestic animal, or that have injured a person but have not been the subject of an action pursuant to the State vicious and potentially dangerous dog law.  The municipality must establish these procedures and requirements by ordinance and it is authorized to require an owner of a dog subject to complaints to post signs or take other action determined necessary by the municipality for the protection of the public.

    “With Assembly Floor Amendments
    (Proposed By Assemblyman Cohen) ADOPTED: DECEMBER 13, 2007
     
    These amendments:
          (1) make changes to the definition of “provoked” in the bill;
          (2) remove certain time limitations by which certain actions may be taken in section 2 of the bill; and
          (3) change the municipal burden of proof with respect to whether the dog was not provoked or that the injury was not accidental from beyond a reasonable doubt to by clear and convincing evidence.

    Clause 15 states – This act shall take effect immediately, and shall apply to all pending cases and cases in the process of being adjudicated as of the date of enactment of this act, and to any dogs under court order for humane destruction as of January 1, 2007 but which have not been destroyed as of the date of enactment of this act.

    The Bill must now go before the Full Assembly.

    See Also: http://www.ipetitions.com/petition/savecongo/

    Michael Grady and fibromyalgia awareness.

    Michael Grady has recently become one of our featured artist’s on FMS Global News. We feature musicians that support fibromyalgia awareness and occasionally musicians that have overcome a disability to return to performing such as world class acoustic guitarist Billy McLaughlin and Tony Denardo of Detroits hard blues/rock band the Muggs.

    “I am still feeling quite honored by how you’ve taken to my music, and especially Open Water, because It was such a strong image that I wrote that song from. Carolyn and I were at a John Gorka concert and he mentioned the frozen lakes in Minnesota, and BAM, this image from my childhood and early teens of frozen Lake Michigan hit me, and I knew it would be a song.

    I grew up one quarter mile north of the Holland State Park “the mouth of Macatawa” And a good family friend actually did get swept off the pier one day, only to return in the spring. The whole song hit me in a split second, and I sat down to write it about a week later, after it had washed around in my brain for a bit.

    Also, I want to thank you for making me the featured artist on your site.”

    Watch Michael perform a solo version of his recent song, “Open Water” which he wrote about growing up on Lake Michigan.

    This performance was part of the 2007 Summit County Songwriter’s Circle showcase.

    More of Michaels music
    http://www.myspace.com/michaelgradymusic

    FMS Global News

    Fibrohugs Support

    Tenderpoints Newsletter

    Follow

    Get every new post delivered to your Inbox.